Procaine: a monoamine oxidase inhibitor in schizophrenia
Bucci, L.
Diseases of the Nervous System 34(7): 389-391
1973
ISSN/ISBN: 0012-3714 PMID: 4782297 Document Number: 63912
Document emailed within 1 workday
Related Documents
MacFarlane, M.D. 1975: Procaine HCl (Gerovital H3): a weak, reversible, fully competitive inhibitor of monoamine oxidase Federation Proceedings 34(1): 108-110Fitzgerald, D.H.; Tipton, K.F.; Lyles, G.A. 1998: Studies on the behaviour of semicarbazide-sensitive amine oxidase in Sprague-Dawley rats treated with the monoamine oxidase inhibitor tranylcypromine Journal of Neural Transmission. Supplementum 52: 259-264
Baron, M.; Levitt, M.; Asnis, L.; Fein, M. 1983: Prolactin levels in schizophrenia: relation to platelet monoamine oxidase, plasma amine oxidase, plasma dopamine-beta-hydroxylase, and erythrocyte catechol-O-methyltransferase activity Biological Psychiatry 18(5): 579-582
Wyatt, R.J.; Potkin, S.G.; Murphy, D.L. 1979: Platelet monoamine oxidase activity in schizophrenia: a review of the data American Journal of Psychiatry 136(4a): 377-385
Arai, Y.; Matsumoto, K.; Kamijo, K. 1972: Monoamine oxidase. 16. Purification of monoamine oxidase from beef liver mitochondria and its enzymatic properties Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 68(4): 400-409
Nabatame, E. 1971: Monoamine oxidase. 12. Substrate specificity of monoamine oxidase in the rabbit brain and liver Nihon Yakurigaku Zasshi. Folia Pharmacologica Japonica 67(4): 374-386
Kagaya, T.; Kajiwara, A.; Nagato, S.; Akasaka, K.; Kubota, A. 1996: E2011 a novel, selective and reversible inhibitor of monoamine oxidase type a Journal of Pharmacology and Experimental Therapeutics 278(1): 243-251
Giller, E.; Bialos, D.; Harkness, L.; Riddle, M. 1984: Assessing treatment response to the monoamine oxidase inhibitor isocarboxazid Journal of Clinical Psychiatry 45(7 Part 2): 44-48
Sweet, R.A.; Brown, E.J.; Heimberg, R.G.; Ciafre, L.; Scanga, D.M.; Cornelius, J.R.; Dube, S.; Forsyth, K.M.; Holt, C.S. 1995: Monoamine oxidase inhibitor dietary restrictions: what are we asking patients to give up? Journal of Clinical Psychiatry 56(5): 196-201
Guze, B.H.; Baxter, L.R.; Rego, J. 1987: Refractory depression treated with high doses of monoamine oxidase inhibitor Journal of Clinical Psychiatry 48(1): 31-32
Hamada, H.; Saito, T.; Torii, J. 1979: A case of optico-neuropathy due to the treatment with monoamine oxidase inhibitor (safrazine) Rinsho Shinkeigaku 19(6): 379-387
Glover, V.; Bhattacharya, S.K.; Sandler, M.; File, S.E. 1981: Benzodiazepines reduce stress-augmented increase in rat urine monoamine oxidase inhibitor Nature 292(5821): 347-349
Gurpegui, M.; Monge, A.; Fuentes, J.A. 1981: Selectivity of an indole-hydrazide derivative as inhibitor of mouse brain type a monoamine oxidase Arzneimittel-Forschung 31(10): 1710-1712
Fuller, R.W.; Hemrick-Luecke, S.K. 1981: Elevation of epinephrine concentration in rat brain by LY51641, a selective inhibitor of type a monoamine oxidase Research Communications in Chemical Pathology and Pharmacology 32(2): 207-221
Bhattacharya, S.K.; Glover, V.; Sandler, M.; Clow, A.; Topham, A.; Bernadt, M.; Murray, R. 1982: Raised endogenous monoamine oxidase inhibitor output in postwithdrawal alcoholics: effects of L-dopa and ethanol Biological Psychiatry 17(7): 829-836
Haefely, W.E.; Kettler, R.; Keller, H.H.; Da Prada, M. 1990: Ro 19-6327, a reversible and highly selective monoamine, oxidase B inhibitor: a novel tool to explore the MAO-B function in humans Advances in Neurology 53: 505-512
Saransaari, P.; Suhonen, J.; Lillrank, S.; Oja, S.S. 1995: Effects of long-term treatment with a monoamine oxidase B inhibitor, selegeline (L-deprenyl), on amino acid transmitter systems in the ageing rat brain Proceedings of the Western Pharmacology Society 38: 13-17
Ricci, A.; Mancini, M.; Strocchi, P.; Bongrani, S.; Bronzetti, E. 1992: Deficits in cholinergic neurotransmission markers induced by ethylcholine mustard aziridinium (AF64A) in the rat hippocampus: sensitivity to treatment with the monoamine oxidase-B inhibitor L-deprenyl Drugs under Experimental and Clinical Research 18(5): 163-171
Khoruzhaia, T.A.; Saakov, B.A. 1975: Change in monoamine content and monoamine oxidase activity in brain structures during experimental allergic encephalomyelitis Biulleten' Eksperimental'noi Biologii i Meditsiny 79(6): 80-82
Gorkin, V.Z. 1986: Characteristics of the disordered regulation of monoamine oxidase activity in pathological states and the regulatory role of the monoamine oxidases Vestnik Akademii Meditsinskikh Nauk SSSR 8: 8-13